# Validation of a Prognostic Method for Assessing the Risk of Distant Metastasis in Early-stage Breast Cancer

> **NCT07372261** · — · ENROLLING_BY_INVITATION · sponsor: **Casa Sollievo della Sofferenza IRCCS** · enrollment: 1000 (estimated)

## Conditions studied

- Breast Cancer Early Stage Breast Cancer (Stage 1-3)

## Interventions

- **DIAGNOSTIC_TEST:** Validation of Prognostic tool

## Key facts

- **NCT ID:** NCT07372261
- **Lead sponsor:** Casa Sollievo della Sofferenza IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-03-10
- **Primary completion:** 2026-06
- **Final completion:** 2026-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-01-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07372261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07372261, "Validation of a Prognostic Method for Assessing the Risk of Distant Metastasis in Early-stage Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07372261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*